Angiotensin II AT2 receptor inhibits smooth muscle cell migration via fibronectin cell production and binding

American Journal of Physiology - Cell Physiology

Volumn 282, Issue 4 51-4, 2002, Pages

  Chassagne, Catherine ^a,d   Adamy, Christophe ^a   Ratajczak, Philippe ^a   Gingras, Bruno ^b   Teiger, Emmanuel ^c   Planus, Emmanuelle ^c   Oliviero, Patricia ^a   Rappaport, Lydie ^a   Samuel, Jane Lise ^a   Meloche, Sylvain ^b  

^a INSERM   (France)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cellular fibronectin; Laminin and fibronectin substrates; Vascular smooth muscle cells

Indexed keywords

ACTIN; AGAROSE; ANGIOTENSIN 2 RECEPTOR; DESMIN; FIBRONECTIN; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; TENASCIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL LINE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; RECEPTOR INTRINSIC ACTIVITY; RIGIDITY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0036083736     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00318.2001     Document Type: Article

References (71)

1. Signalling mechanisms in the regulation of vascular cell migration
2. Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin
3. 2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
4. The biology of restenosis
5. Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries
6. Influence of the angiotensin system on endothelial and smooth muscle cell migration
7. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy
8. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: Relationship to microfilament dissociation and altered cell morphology
9. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy
10. Assignment of the human angiotensin II type 2 receptor gene (AGTR2) to chromosome Xq22-q 23 by fluorescence in situ hybridization
11. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension
12. Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages
13. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
14. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
15. International union of pharmacology. XXIII. The angiotensin II receptors
16. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes
17. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength
18. 2 antagonists
19. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin I receptors
20. Vascular remodelling: Mechanisms and implications
21. Divergent regulation by growth factors and cytokines of 95 kD and 72 kD gelatinase and tissue inhibitors of metalloproteinase-1, -2, -3 in rabbit aortic smooth muscle cells
22. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides
23. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells
24. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity
25. 2) receptor domains mediating high-affinity CGP42112A binding and receptor activation
26. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury
27. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells
28. Oligodendrocyte precursor (O-2A progenitor cells) migration; a model for the study of cell migration in the developing central nervous system
29. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
30. Extracellular matrix and pulmonary hypertension: Control of vascular smooth muscle cells contractility
31. 2 receptors prevents the effect of angiotensin II on the rat vascular structure
32. Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-β1
33. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells
34. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery
35. 2 receptors by endogenous angiotensin II is involved in flow-induced dilatation in rat resistance arteries
36. Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa
37. Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells
38. Improved retroviral vectors for gene transfer and expression
39. Effects of angiotensin II on visual neurons in the superficial laminae of the hamster's superior colliculus
40. Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-b synthesis via transcriptional and post-transcriptional mechanisms
41. Superfibronectin is a functionally distinct form of fibronectin
42. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors
43. 1 receptor: Gain-of-function study using gene transfer
44. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury
45. Role of angiotensin II in injury-induced neointima formation in rats
46. 5β1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury
47. Role of collagenase in mediating in vitro alveolar epithelial wound repair
48. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
49. 1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury
50. Storage of phosphorylated desmin in a familial myopathy
51. Measurement of cell proliferation in microculture using Hoechst 33342 for the rapid semiautomated microfluorimetric determination of chromatin DNA
52. Integrin involvement in gliastoma multiforme: Possible regulation by NF-κB
53. The pathogenesis of atherosclerosis: A perspective for the 1990s
54. 2 in vascular smooth muscle cells: Molecular mechanisms
55. Fibronectin and its receptors
56. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II
57. Smooth muscle migration in vascular development and pathogenesis
58. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat
59. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration
60. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain
61. 2+-dependent manner through a decrease of cyclic guanosine 3′,5′-monophosphate production in cultured porcine adrenal medullary chromaffin cells
62. Angiotensin II receptors and angiotensin II receptor antagonists
63. A comparison of the migration patterns of normal and malignant cells in two assays system
64. Changes in expression of angiotensin receptor subtypes in the rat aorta during development
65. Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation
66. Control of cytoskeletal mechanisms by extracellular matrix, cell shape and mechanical tension
67. Role of cellular tone and microenvironmental conditions on cytoskeleton stiffness assessed by tensegrity model
68. 2 receptors in the normal and failing human heart
69. Central role of the MAPK pathway in ANG II-mediated DNA synthesis and migration in rat vascular smooth muscle cells
70. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study
71. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor